Codexis Azione

Codexis Spese R&S

Il Spese per ricerca e sviluppo di Codexis (CDXS) al 18 ago 2026 è 52,31 Mio. USD. L'anno precedente, Spese per ricerca e sviluppo era 46,26 Mio. USD — una variazione del 13,06% (superiore).

Spese R&S

52,31 Mio.USD

YoY

13,06%

Ultimo aggiornamento:

Spese per ricerca e sviluppo di Codexis ammonta a 2026 52,31 Mio. USD. Spese per ricerca e sviluppo di Codexis ammontava a 2025 46,26 Mio. USD. Diminuisce del 13,06% superiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Codexis Analisi delle Azioni

Cosa fa Codexis? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Codexis azioni

Spese per ricerca e sviluppo di Codexis è 52,31 Mio. USD nel 2026.

Il Spese per ricerca e sviluppo di Codexis è passato da 46,26 Mio. USD a 52,31 Mio. USD, con una variazione del 13,06 %. Il valore è superiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Codexis di Spese per ricerca e sviluppo dal 2006, con valori annuali, grafici e analisi dettagliate.

Le spese di R&S rappresentano i costi sostenuti nella ricerca e nello sviluppo di nuovi prodotti, servizi o processi. Le elevate spese in R&S possono segnalare innovazione e potenziale di crescita futura.

Il USD di Spese per ricerca e sviluppo è un fattore chiave per gli investitori. I cambiamenti in questa metrica possono segnalare il miglioramento o il deterioramento dei fondamentali, impattando direttamente il prezzo delle azioni. Su Eulerpool puoi tracciare il Codexis di Spese per ricerca e sviluppo storicamente e in tempo reale.

Access this data via the Eulerpool API

Conto economico — Codexis

Tutte le Metriche Finanziarie — Codexis